On October 16, 2025, the Xinyan Care team successfully completed an on-site training session for the Thermo Fisher Scientific (PPD) team at Hengji Building, Shanghai, along with an online training program for Thermo Fisher’s U.S.-based team. This achievement marks another solid step forward in Xinyan Care’s commitment to advancing innovation in cardiac health.

Moving forward, Xinyan Care will work hand in hand with Thermo Fisher Scientific and six leading Class III Grade A hospitals in China to launch an atrial fibrillation screening project. Leveraging the company’s YM Heart Series portable ECG monitoring devices, Xinyan Care aims to provide cutting-edge dynamic ECG monitoring solutions to safeguard the heart health of more people worldwide.

Guided by its philosophy of empowering health through technology, Xinyan Care is dedicated to ensuring that every heartbeat is cared for and every life is protected. Through close collaboration and technological innovation, Xinyan Care and Thermo Fisher will jointly promote early screening and prevention of cardiovascular diseases, contributing to the ongoing advancement of global health and well-being.